Have a personal or library account? Click to login
Acute hemolytic transfusion reaction secondary to anti-Fy3 Cover

Acute hemolytic transfusion reaction secondary to anti-Fy3

Paid access
|Apr 2020

References

  1. Cutbush M, Mollison PL. The Duffy blood group system. Heredity 1950;4:383-9.10.1038/hdy.1950.3114802995
  2. Donahue RP, Bias WB, Renwick JH, McKusick VA. Probable assignment of the Duffy blood group locus to chromosome 1 in man. Proc Natl Acad Sci U S A 1968;61:949-55.10.1073/pnas.61.3.9493054205246559
  3. Chaudhuri A, Polyakova J, Zbrzezna V, Pogo AO. The coding sequence of Duffy blood group gene in humans and simians: restriction fragment length polymorphism, antibody and malarial parasite specificities, and expression in nonerythroid tissues in Duffy-negative individuals. Blood 1995; 85:615-21.10.1182/blood.V85.3.615.bloodjournal853615
  4. Iwamoto S, Omi T, Kajii E, Ikemoto S. Genomic organization of the glycoprotein D gene: Duffy blood group Fya/Fyb alloantigen system is associated with a polymorphism at the 44-amino acid residue. Blood 1995;85:622-6.10.1182/blood.V85.3.622.bloodjournal853622
  5. Mallinson G, Soo KS, Schall TJ, et al. Mutations in the erythrocyte chemokine receptor (Duffy) gene: the molecular basis of the Fya/Fyb antigens and identification of a deletion in the Duffy gene of an apparently healthy individual with the Fy(a–b–) phenotype. Br J Haematol 1995;90: 823-9.10.1111/j.1365-2141.1995.tb05202.x7669660
  6. Tournamille C, Le Van Kim C, Gane P, et al. Molecular basis and PCR-DNA typing of the Fya/Fyb blood group polymorphism. Hum Genet 1995;95:407-10.10.1007/BF002089657705836
  7. Tournamille C, Le Van Kim C, Gane P, et al. Close association of the first and fourth extracellular domains of the Duffy antigen/receptor for chemokines by a disulfide bond is required for ligand binding. J Biol Chem 1997;272:16274-80.10.1074/jbc.272.26.162749195930
  8. Wasniowska K, Lisowska E, Halverson GR, et al. The Fya, Fy6 and Fy3 epitopes of the Duffy blood group system recognized by new monoclonal antibodies: identification of a linear Fy3 epitope. Br J Haematol 2004;124:118-22.10.1046/j.1365-2141.2003.04725.x14675417
  9. Wasniowska K, Petit-LeRoux Y, Tournamille C, et al. Structural characterization of the epitope recognized by the new anti-Fy6 monoclonal antibody NaM 185-2C3. Transfus Med 2002;12:205-11.10.1046/j.1365-3148.2002.00373.x12164140
  10. Tournamille C, Filipe A, Wasniowska K, et al. Structure-function analysis of the extracellular domains of the Duffy antigen/receptor for chemokines: characterization of antibody and chemokine binding sites. Br J Haematol 2003;122:1014-23.10.1046/j.1365-2141.2003.04533.x12956774
  11. Hadley TJ, Peiper SC. From malaria to chemokine receptor: the emerging physiologic role of the Duffy blood group antigen. Blood 1997;89: 3077-91.10.1182/blood.V89.9.3077
  12. Sanger R, Race RR, Jack J. The Duffy blood groups of New York negroes: the phenotype Fy(a–b–). Br J Haematol 1955;1:370-4.10.1111/j.1365-2141.1955.tb05523.x
  13. Tournamille C, Colin Y, Cartron JP, Le Van Kim C. Disruption of a GATA motif in the Duffy gene promoter abolishes erythroid gene expression in Duffy-negative individuals. Nat Genet 1995;10: 224-8.10.1038/ng0695-224
  14. Peiper SC, Wang ZX, Neote K, et al. The Duffy antigen/receptor for chemokines (DARC) is expressed in endothelial cells of Duffy negative individuals who lack the erythrocyte receptor. J Exp Med 1995;181:1311-7.10.1084/jem.181.4.1311
  15. Albrey JA, Vincent EE, Hutchinson J, et al. A new antibody, anti-Fy3, in the Duffy blood group system. Vox Sang 1971;20:29-35.10.1111/j.1423-0410.1971.tb01797.x
  16. Buchanan DI, Sinclair M, Sanger R, et al. An Alberta Cree Indian with a rare Duffy antibody, anti-Fy 3. Vox Sang 1976;30:114-21.10.1111/j.1423-0410.1976.tb02801.x
  17. Libich M, Kout M, Giles CM. Fy(a–b–) phenotype in Czechoslovakia. Vox Sang 1978;35:423-5.10.1111/j.1423-0410.1978.tb02960.x
  18. Rios M, Chaudhuri A, Mallinson G, et al. New genotypes in Fy(a–b–) individuals: nonsense mutations (Trp to stop) in the coding sequence of either FYA or FYB. Br J Haematol 2000;108: 448-54.10.1046/j.1365-2141.2000.01882.x
  19. Oberdorfer CE, Kahn B, Moore V, et al. A second example of anti-Fy3 in the Duffy blood group system. Transfusion 1974;14:608-11.10.1111/j.1537-2995.1974.tb04588.x
  20. Kosinski KS, Molthan L, White L. Three examples of anti-Fy3 produced in Negroes. Rev Fr Transfus Immunohematol 1984;27:619-24.10.1016/S0338-4535(84)80083-5
  21. Le Pennec PY, Rouger P, Klein MT, et al. Study of anti-Fya in five black Fy(a–b–) patients. Vox Sang 1987;52:246-9.
  22. Sosler SD, Perkins JT, Fong K, Saporito C. The prevalence of immunization to Duffy antigens in a population of known racial distribution. Transfusion 1989;29:505-7.10.1046/j.1537-2995.1989.29689318448.x
  23. Vengelen-Tyler V. Anti-Fya preceding anti-Fy3 or -Fy5: a study of five cases. Transfusion 1985;25;482 (abstract).
  24. Horuk R, Chitnis CE, Darbonne WC, et al. A receptor for the malarial parasite Plasmodium vivax: the erythrocyte chemokine receptor. Science 1993;261:1182-4.10.1126/science.7689250
  25. Chaudhuri A, Zbrzezna V, Johnson C, et al. Purification and characterization of an erythrocyte membrane protein complex carrying Duffy blood group antigenicity. Possible receptor for Plasmodium vivax and Plasmodium knowlesi malaria parasite. J Biol Chem 1989;264:13770-4.10.1016/S0021-9258(18)80067-9
  26. Miller LH, Mason SJ, Clyde DF, McGinniss MH. The resistance factor to Plasmodium vivax in blacks. The Duffy-blood-group genotype, FyFy. N Engl J Med 1976;295:302-4.10.1056/NEJM197608052950602
  27. Iwamoto S, Li J, Omi T, et al. Identification of a novel exon and spliced form of Duffy mRNA that is the predominant transcript in both erythroid and postcapillary venule endothelium. Blood 1996;87:378-85.10.1182/blood.V87.1.378.378
  28. Pogo AO, Chaudhuri A. The Duffy protein: a malarial and chemokine receptor. Semin Hematol 2000;37:122-9.10.1016/S0037-1963(00)90037-4
  29. Cartron JP, Colin Y. Structural and functional diversity of blood group antigens. Transfus Clin Biol 2001;8:163-99.10.1016/S1246-7820(01)00142-2
  30. Darbonne WC, Rice GC, Mohler MA, et al. Red blood cells are a sink for interleukin 8, a leukocyte chemotaxin. J Clin Invest 1991;88:1362-9.10.1172/JCI1154422956071918386
  31. Horuk R, Colby TJ, Darbonne WC, et al. The human erythrocyte inflammatory peptide (chemokine) receptor. Biochemical characterization, solubilization, and development of a binding assay for the soluble receptor. Biochemistry 1993;32: 5733-8.10.1021/bi00073a0028389192
  32. Liu XH, Hadley TJ, Xu L, et al. Up-regulation of Duffy antigen receptor expression in children with renal disease. Kidney Int 1999;55:1491-500.10.1046/j.1523-1755.1999.00385.x10201015
  33. Segerer S, Cui Y, Eitner F, et al. Expression of chemokines and chemokine receptors during human renal transplant rejection. Am J Kidney Dis 2001;37:518-31.10.1053/ajkd.2001.22076
  34. Segerer S, Bohmig GA, Exner M, et al. When renal allografts turn DARC. Transplantation 2003;75: 1030-4.10.1097/01.TP.0000054679.91112.6F12698093
DOI: https://doi.org/10.21307/immunohematology-2019-392 | Journal eISSN: 1930-3955 | Journal ISSN: 0894-203X
Language: English
Page range: 48 - 52
Published on: Apr 21, 2020
Published by: American National Red Cross
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2020 H. Olteanu, D. Gerber, K. Partridge, R. Sarode, published by American National Red Cross
This work is licensed under the Creative Commons License.